{"entity":{"type":"insider","cik":"0001790933","url":"/insider/0001790933","json_url":"/insider/0001790933.json","name":"WINDSOR JAMES BRIAN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2019-10-29","last":"2026-05-13","span_basis":"filed_date"},"name_variants":[{"name":"WINDSOR JAMES BRIAN","source":"filing","n_filings":6,"first_seen":"2019-10-29","last_seen":"2026-05-13"}],"transactions":[{"id":5959470,"accession":"0001193125-26-220718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-220718","line_url":"/filing/0001193125-26-220718#line-1","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"Rein Therapeutics, Inc.","issuer_ticker":"RNTX","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001790933","owner_name":"WINDSOR JAMES BRIAN","owner_display_name":"WINDSOR JAMES BRIAN","owner_url":"/insider/0001790933","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common stock , $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":27046.0,"shares_owned_after_display":"27,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-13","scope":"insider"},{"id":2083542,"accession":"0000950170-24-134522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-134522","line_url":"/filing/0000950170-24-134522","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"Aileron Therapeutics, Inc.","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001790933","owner_name":"WINDSOR JAMES BRIAN","owner_display_name":"WINDSOR JAMES BRIAN","owner_url":"/insider/0001790933","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":2.244025,"price_display":"2.24","price_state":"stated","total_value":897.61,"total_display":"897.61","total_whole":"898","shares_owned_after":239.0,"shares_owned_after_display":"239","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-09","scope":"insider","n_lines":2},{"id":8646385,"accession":"0000950170-23-071200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-071200","line_url":"/filing/0000950170-23-071200#line-1","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001790933","owner_name":"WINDSOR JAMES BRIAN","owner_display_name":"WINDSOR JAMES BRIAN","owner_url":"/insider/0001790933","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225.0,"shares_display":"225","price_per_share":3.37,"price_display":"3.37","price_state":"stated","total_value":758.25,"total_display":"758.25","total_whole":"758","shares_owned_after":225.0,"shares_owned_after_display":"225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-18","scope":"insider"},{"id":8530748,"accession":"0000950170-23-065545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-065545","line_url":"/filing/0000950170-23-065545#line-1","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":"0001790933","owner_name":"WINDSOR JAMES BRIAN","owner_display_name":"WINDSOR JAMES BRIAN","owner_url":"/insider/0001790933","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5076.0,"shares_display":"5,076","price_per_share":1.9675,"price_display":"1.97","price_state":"stated","total_value":9987.03,"total_display":"9,987.03","total_whole":"9,987","shares_owned_after":5122.0,"shares_owned_after_display":"5,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":2121273,"accession":"0001213900-20-041813","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-20-041813","line_url":"/filing/0001213900-20-041813#line-2","is_derivative":false,"issuer_cik":"0001733413","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001733413","owner_cik":"0001790933","owner_name":"WINDSOR JAMES BRIAN","owner_display_name":"WINDSOR JAMES BRIAN","owner_url":"/insider/0001790933","role":"Director, Officer (Chief Science Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.8,"price_display":"15.80","price_state":"stated","total_value":395000.0,"total_display":"395,000.00","total_whole":"395,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-07","filed_date":"2020-12-09","scope":"insider"},{"id":8620137,"accession":"0001213900-19-021428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-19-021428","line_url":"/filing/0001213900-19-021428#line-1","is_derivative":false,"issuer_cik":"0001733413","issuer_name":"TFF Pharmaceuticals, Inc.","issuer_ticker":"TFFP","issuer_name_source":null,"issuer_url":"/issuer/0001733413","owner_cik":"0001790933","owner_name":"WINDSOR JAMES BRIAN","owner_display_name":"WINDSOR JAMES BRIAN","owner_url":"/insider/0001790933","role":"Director, Officer (Chief Science Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Science Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001420565","name":"Rein Therapeutics, Inc.","url":"/issuer/0001420565","role":"Director, Officer","n_filings":4,"first_seen":"2023-11-21","last_seen":"2026-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001733413","name":"TFF Pharmaceuticals, Inc.","url":"/issuer/0001733413","role":"Director, Officer (Chief Science Officer)","n_filings":2,"first_seen":"2019-10-29","last_seen":"2020-12-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001790933","retrieved_at":"2026-08-22T12:32:06+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}